ro 31-8220 has been researched along with zinterol in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adamy, C; Ait-Mamar, B; Bouabdallah, A; Cailleret, M; Candiani, G; Defer, N; Duvaldestin, P; Pavoine, C; Pecker, F; Rucker-Martin, C | 1 |
1 other study(ies) available for ro 31-8220 and zinterol
| Article | Year |
|---|---|
The cytosolic phospholipase A2 pathway, a safeguard of beta2-adrenergic cardiac effects in rat.
Topics: Adenylyl Cyclases; Animals; Calcium; Calcium-Transporting ATPases; Caveolin 1; Caveolin 3; Caveolins; Cell Membrane; Cyclic AMP-Dependent Protein Kinases; Cytosol; Enzyme Inhibitors; Ethanolamines; Immunoblotting; Immunohistochemistry; Indoles; Isoquinolines; Lysophospholipase; Microscopy, Confocal; Myocardium; Myocytes, Cardiac; NG-Nitroarginine Methyl Ester; Pertussis Toxin; Phospholipases A; Phospholipases A2; Phosphorylation; Rats; Receptors, Adrenergic, beta-2; Sarcoplasmic Reticulum; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Serine; Sulfonamides; Time Factors | 2005 |